C16 Ceramide (d18:1/16:0) from Cayman Chemical

Supplier Page

Supplier Page from
Cayman Chemical for
C16 Ceramide (d18:1/16:0)

Request Info

Description

A sphingolipid; levels are increased by PPMP or MAPP in isolated human neutrophils and are correlated with an increase in apoptosis; accumulates in the lungs of patients with cystic fibrosis compared with the lungs of patients with pulmonary hypertension; plasma levels are increased in patients with acute coronary syndrome, and an increased plasma ratio of C16 to C24:0 ceramide is associated with major adverse cardiac events; levels are increased in tumor tissue from patients with breast cancer and is associated with metastatic cancer